How HIV-1 Nef hijacks the AP-2 clathrin adaptor to downregulate CD4

eLife

Volumn 2014, Issue 3, 2014, Pages

  Ren, Xuefeng ^a,b,c   Park, Sang Yoon ^c   Bonifacino, Juan S ^c   Hurley, James H ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTOR PROTEIN; CLATHRIN; NEF PROTEIN;

ADAPTIVE IMMUNITY; ANTIGEN BINDING; ARTICLE; CD4 LYMPHOCYTE COUNT; CONTROLLED STUDY; CRYSTALLIZATION; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; INNATE IMMUNITY; ISOTHERMAL TITRATION CALORIMETRY; LYMPHOCYTE ACTIVATION; MUTAGENESIS; MYRISTYLATION; NUCLEAR MAGNETIC RESONANCE; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; VIRION; VIRUS GENOME; VIRUS MUTATION; VIRUS REPLICATION;

EID: 84898733948     PISSN: None     EISSN: 2050084X     Source Type: Journal    
DOI: 10.7554/eLife.01754.001     Document Type: Article

References (59)

1. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, Mccoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta crystallographica Section D, Biological crystallography 66:213-221. doi: 10.1107/s0907444909052925.
2. Aiken C, Konner J, Landau N, Lenburg M, Trono D. 1994. Nef induces CD4 endocytosis: requirement for a critical dileucine motif in the membrane-proximal CD4 cytoplasmic domain. Cell 76:853-864. doi: 10.1016/0092-8674(94)90360-3.
3. Aiken C, Krause L, Chen Y, Trono D. 1996. Mutational analysis of HIV-1 Nef: identification of two mutants that are temperature-sensitive for CD4 downregulation. Virology 217:293-300. doi: 10.1006/viro.1996.0116.
4. Arold S, Franken P, Strub M, Hoh F, Benichou S, Benarous R, Dumas C. 1997. The crystal structure of HIV-1 Nef protein bound to the Fyn kinase SH3 domain suggests a role for this complex in altered T cell receptor signaling. Structure 5:1361-1372. doi: 10.1016/S0969-2126(97)00286-4.
5. Benson R, Sanfridson A, Ottinger J, Doyle C, Cullen B. 1993. Downregulation of cell-surface CD4 expression by simian immunodeficiency virus Nef prevents viral super infection. The Journal of Experimental Medicine 177:1561-1566. doi: 10.1084/jem.177.6.1561.
6. Bonifacino J, Traub L. 2003. Signals for sorting of transmembrane proteins to endosomes and lysosomes. Annual Review of Biochemistry 72:395-447. doi: 10.1146/annurev.biochem.72.121801.161800.
7. Bowers K, Pitcher C, Marsh M. 1997. CD4: a co-receptor in the immune response and HIV infection. International Journal of Biochemistry & Cell Biology 29:871-875. doi: 10.1016/S1357-2725(96)00154-9.
8. Bresnahan P, Yonemoto W, Ferrell S, Williams-Herman D, Geleziunas R, Greene W. 1998. A dileucine motif in HIV-1 Nef acts as an internalization signal for CD4 downregulation and binds the AP-1 clathrin adaptor. Current Biology 8:1235-1238. doi: 10.1016/S0960-9822(07)00517-9.
9. Breuer S, Schievink SI, Schulte A, Blankenfeldt W, Fackler OT, Geyer M. 2011. Molecular design, functional characterization and structural basis of a protein inhibitor against the HIV-1 pathogenicity factor nef. PLOS ONE 6:e20033. doi: 10.1371/journal.pone.0020033.
10. Burtey A, Rappoport J, Bouchet J, Basmaciogullari S, Guatelli J, Simon S, Benichou S, Benmerah A. 2007. Dynamic interaction of HIV-1 Nef with the clathrin-mediated endocytic pathway at the plasma membrane. Traffic 8:61-76. doi: 10.1111/j.1600-0854.2006.00512.x.
11. Canagarajah B, Ren X, Bonifacino JS, Hurley JH. 2013. The clathrin adaptor complexes as a paradigm for membrane-associated allostery. Protein Science 22:517-529. doi: 10.1002/pro.2235.
12. Carl S, Daniels R, Iafrate A, Easterbrook P, Greenough T, Skowronski J, Kirchhoff F. 2000. Partial "repair" of defective NEF genes in a long-term nonprogressor with human immunodeficiency virus type 1 infection. The Journal of Infectious Diseases 181:132-140. doi: 10.1086/315187.
13. Chaudhuri R, Lindwasser O, Smith W, Hurley J, Bonifacino J. 2007. Downregulation of CD4 by human immunodeficiency virus type 1 Nef is dependent on clathrin and involves direct interaction of Nef with the AP2 clathrin adaptor. Journal of Virology 81:3877-3890. doi: 10.1128/JVI.02725-06.
14. Chaudhuri R, Mattera R, Lindwasser O, Robinson M, Bonifacino J. 2009. A basic patch on alpha-adaptin is required for binding of human immunodeficiency virus type 1 Nef and cooperative assembly of a CD4-Nef-AP-2 complex. Journal of Virology 83:2518-2530. doi: 10.1128/JVI.02227-08.
15. Coleman S, Day J, Guatelli J. 2001. The HIV-1 Nef protein as a target for antiretroviral therapy. Expert Opinion on Therapeutic Targets 5:1-22. doi: 10.1517/14728222.5.1.1.
16. Collins BM, Mccoy AJ, Kent HM, Evans PR, Owen DJ. 2002. Molecular architecture and functional model of the endocytic AP2 complex. Cell 109:523-535. doi: 10.1016/S0092-8674(02)00735-3.
17. Craig HM, Pandori MW, Guatelli JC. 1998. Interaction of HIV-1 Nef with the cellular dileucine-based sorting pathway is required for CD4 down-regulation and optimal viral infectivity. Proceedings of the National Academy of Sciences of the United States of America 95:11229-11234. doi: 10.1073/pnas.95.19.11229.
18. daSilva L, Sougrat R, Burgos P, Janvier K, Mattera R, Bonifacino J. 2009. Human immunodeficiency virus type 1 Nef protein targets CD4 to the multivesicular body pathway. Journal of Virology 83:6578-6590. doi: 10.1128/JVI.00548-09.
19. Deacon N, Tsykin A, Solomon A, Smith K, Ludford-Menting M, Hooker D, Mcphee D, Greenway A, Ellett A, Chatfield C, Lawson V, Crowe S, Maerz A, Sonza S, Learmont J, Sullivan J, Cunningham A, Dwyer D, Dowton D, Mills J. 1995. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science 270:988-991. doi: 10.1126/science.270.5238.988.
20. DeLano WL. 2002. The PyMOL molecular graphics system. DeLano Scientific. http://www.pymol.org/
21. Doray B, Lee I, Knisely J, Bu G, Kornfeld S. 2007. The gamma/sigma1 and alpha/sigma2 hemicomplexes of clathrin adaptors AP-1 and AP-2 harbor the dileucine recognition site. Molecular Biology of the Cell 18:1887-1896. doi: 10.1091/mbc.E07-01-0012.
22. Emsley P, Lohkamp B, Scott WG, Cowtan K. 2010. Features and development of Coot. Acta Crystallographica Section D, Biological Crystallography 66:486-501. doi: 10.1107/S0907444910007493.
23. Foster J, Garcia J. 2008. HIV-1 Nef: at the crossroads. Retrovirology 5:84. doi: 10.1186/1742-4690-5-84.
24. Foti M, Mangasarian A, Piguet V, Lew D, Krause K, Trono D, Carpentier J. 1997. Nef-mediated clathrin-coated pit formation. The Journal of Cell Biology 139:37-47. doi: 10.1083/jcb.139.1.37.
25. Frankel A, Young J. 1998. HIV-1: fifteen proteins and an RNA. Annual Review of Biochemistry 67:1-25. doi: 10.1146/annurev.biochem.67.1.1.
26. Garcia J, Miller A. 1991. Serine phosphorylation-independent downregulation of cell-surface CD4 by nef. Nature 350:508-511. doi: 10.1038/350508a0.
27. Glushakova S, Munch J, Carl S, Greenough T, Sullivan J, Margolis L, Kirchhoff F. 2001. CD4 down-modulation by human immunodeficiency virus type 1 Nef correlates with the efficiency of viral replication and with CD4(+) T-cell depletion in human lymphoid tissue ex vivo. Journal of Virology 75:10113-10117. doi: 10.1128/JVI.75.21.10113-10117.2001.
28. Gorry P, Mcphee D, Verity E, Dyer W, Wesselingh S, Learmont J, Sullivan J, Roche M, Zaunders J, Gabuzda D, Crowe S, Mills J, Lewin S, Brew B, Cunningham A, Churchill M. 2007. Pathogenicity and immunogenicity of attenuated, nef-deleted HIV-1 strains in vivo. Retrovirology 4:66. doi: 10.1186/1742-4690-4-66.
29. Greenberg M, Detulleo L, Rapoport I, Skowronski J, Kirchhausen T. 1998. A dileucine motif in HIV-1 Nef is essential for sorting into clathrin-coated pits and for downregulation of CD4. Current Biology 8:1239-1242. doi: 10.1016/S0960-9822(07)00518-0.
30. Greenberg ME, Bronson S, Lock M, Neumann M, Pavlakis GN, Skowronski J. 1997. Co-localization of HIV-1 Nef with the AP-2 adaptor protein complex correlates with Nef-induced CD4 down-regulation. The EMBO Journal 16:6964-6976. doi: 10.1093/emboj/16.23.6964.
31. Grzesiek S, Bax A, Clore G, Gronenborn A, Hu J, Kaufman J, Palmer I, Stahl S, Wingfield P. 1996a. The solution structure of HIV-1 Nef reveals an unexpected fold and permits delineation of the binding surface for the SH3 domain of Hck tyrosine protein kinase. Nature Structural Biology 3:340-345. doi: 10.1038/nsb0496-340.
32. Grzesiek S, Bax A, Hu J, Kaufman J, Palmer I, Stahl S, Tjandra N, Wingfield P. 1997. Refined solution structure and backbone dynamics of HIV-1 Nef. Protein Science: a Publication of the Protein Society 6:1248-1263. doi: 10.1002/pro.5560060613.
33. Grzesiek S, Stahl SJ, Wingfield PT, Bax A. 1996b. The CD4 determinant for downregulation by HIV-1 Nef directly binds to Nef. mapping of the Nef binding surface by NMR. Biochemistry 35:10256-10261. doi: 10.1021/bi9611164.
34. Guy B, Kieny M, Riviere Y, Le Peuch C, Dott K, Girard M, Montagnier L, Lecocq J. 1987. HIV F/3' orf encodes a phosphorylated GTP-binding protein resembling an oncogene product. Nature 330:266-269. doi: 10.1038/330266a0.
35. Horenkamp F, Breuer S, Schulte A, Lulf S, Weyand M, Saksela K, Geyer M. 2011. Conformation of the dileucine-based sorting motif in HIV-1 Nef revealed by intermolecular domain assembly. Traffic 12:867-877. doi: 10.1111/j.1600-0854.2011.01205.x.
36. Hua J, Blair W, Truant R, Cullen BR. 1997. Identification of regions in HIV-1 Nef required for efficient downregulation of cell surface CD4. Virology 231:231-238. doi: 10.1006/viro.1997.8517.
37. Jackson L, Kelly B, Mccoy A, Gaffry T, James L, Collins B, Honing S, Evans P, Owen D. 2010. A large-scale conformational change couples membrane recruitment to cargo binding in the AP2 clathrin adaptor complex. Cell 141:1220-1229. doi: 10.1016/j.cell.2010.05.006.
38. Jaeger S, Cimermancic P, Gulbahce N, Johnson JR, Mcgovern KE, Clarke SC, Shales M, Mercenne G, Pache L, Li K, Hernandez H, Jang GM, Roth SL, Akiva E, Marlett J, Stephens M, D'orso I, Fernandes J, Fahey M, Mahon C, O'donoghue AJ, Todorovic A, Morris JH, Maltby DA, Alber T, Cagney G, Bushman FD, Young JA, Chanda SK, Sundquist WI, Kortemme T, Hernandez RD, Craik CS, Burlingame A, Sali A, Frankel AD, Krogan NJ. 2011. Global landscape of HIV-human protein complexes. Nature 481:365-370. doi: 10.1038/nature10719.
39. Janvier K, Kato Y, Boehm M, Rose J, Martina J, Kim B, Venkatesan S, Bonifacino J. 2003. Recognition of dileucine-based sorting signals from HIV-1 Nef and LIMP-II by the AP-1 gamma-sigma1 and AP-3 delta-sigma3 hemicomplexes. The Journal of Cell Biology 163:1281-1290. doi: 10.1083/jcb.200307157.
40. Jia X, Singh R, Homann R, Yang H, Guatelli J, Xiong X. 2012. Structural basis of evasion of cellular adaptive immunity by HIV-1 Nef. Nature Structural & Molecular Biology 19:701-706. doi: 10.1038/nsmb.2328.
41. Jin Y, Cai C, Zhang X, Zhang H, Hirst J, Burakoff S. 2005. HIV Nef-mediated CD4 down-regulation is adaptor protein complex 2 dependent. Journal of Immunology 175:3157-3164.
42. Jin YJ, Cai CY, Mezei M, Ohlmeyer M, Sanchez R, Burakoff SJ. 2013. Identification of a novel binding site between HIV type 1 nef c-terminal flexible loop and AP2 required for nef-mediated CD4 downregulation. AIDS Research and Human Retroviruses 29:725-731. doi: 10.1089/AID.2012.0286.
43. Kelly BT, Mccoy AJ, Spate K, Miller SE, Evans PR, Honing S, Owen DJ. 2008. A structural explanation for the binding of endocytic dileucine motifs by the AP2 complex. Nature 456:976-979. doi: 10.1038/nature07422.
44. Kirchhoff F, Greenough T, Brettler D, Sullivan J, Desrosiers R. 1995. Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection. The New England Journal of Medicine 332:228-232. doi: 10.1056/NEJM199501263320405.
45. Lama J, Mangasarian A, Trono D. 1999. Cell-surface expression of CD4 reduces HIV-1 infectivity by blocking Env incorporation in a Nef-and Vpu-inhibitable manner. Current Biology 9:622-631. doi: 10.1016/S0960-9822(99)80284-X.
46. Lee C, Saksela K, Mirza U, Chait B, Kuriyan J. 1996. Crystal structure of the conserved core of HIV-1 Nef complexed with a Src family SH3 domain. Cell 85:931-942. doi: 10.1016/S0092-8674(00)81276-3.
47. Lindwasser O, Smith W, Chaudhuri R, Yang P, Hurley J, Bonifacino J. 2008. A diacidic motif in human immunodeficiency virus type 1 Nef is a novel determinant of binding to AP-2. Journal of Virology 82:1166-1174. doi: 10.1128/JVI.01874-07.
48. Mattera R, Boehm M, Chaudhuri R, Prabhu Y, Bonifacino JS. 2011. Conservation and diversification of dileucine signal recognition by adaptor protein (AP) complex variants. The Journal of Biological Chemistry 286:2022-2030. doi: 10.1074/jbc.M110.197178.
49. McCoy AJ, Grosse-Kunstleve RW, Adams PD, Winn MD, Storoni LC, Read RJ. 2007. Phaser crystallographic software. Journal of Applied Crystallography 40:658-674. doi: 10.1107/S0021889807021206.
50. Owen D, Collins B, Evans P. 2004. Adaptors for clathrin coats: structure and function. Annual Review of Cell and Developmental Biology 20:153-191. doi: 10.1146/annurev.cellbio.20.010403.104543.
51. Preusser A, Briese L, Baur AS, Willbold D. 2001. Direct in vitro binding of full-length human immunodeficiency virus type 1 Nef protein to CD4 cytoplasmic domain. Journal of Virology 75:3960-3964. doi: 10.1128/JVI.75.8.3960-3964.2001.
52. Ren X, Farias GG, Canagarajah B, Bonifacino JS, Hurley JH. 2013. Structural basis for recruitment and activation of the AP-1 clathrin adaptor complex by Arf1. Cell 152:755-767. doi: 10.1016/j.cell.2012.12.042.
53. Rhee S, Marsh J. 1994. Human immunodeficiency virus type 1 Nef-induced down-modulation of CD4 is due to rapid internalization and degradation of surface CD4. Journal of Virology 68:5156-5163.
54. Ross T, Oran A, Cullen B. 1999. Inhibition of HIV-1 progeny virion release by cell-surface CD4 is relieved by expression of the viral Nef protein. Current Biology 9:613-621. doi: 10.1016/S0960-9822(99)80283-8.
55. Sheffield P, Garrard S, Derewenda Z. 1999. Overcoming expression and purification problems of RhoGDI using a family of "parallel" expression vectors. Protein Expression and Purification 15:34-39. doi: 10.1006/prep.1998.1003.
56. Skowronski J, Parks D, Mariani R. 1993. Altered T cell activation and development in transgenic mice expressing the HIV-1 nef gene. The EMBO Journal 12:703-713.
57. Tan S. 2001. A modular polycistronic expression system for overexpressing protein complexes in Escherichia coli. Protein Expression and Purification 21:224-234. doi: 10.1006/prep.2000.1363.
58. Yu G, Felsted R. 1992. Effect of myristoylation on p27 nef subcellular distribution and suppression of HIV-LTR transcription. Virology 187:46-55. doi: 10.1016/0042-6822(92)90293-X.
59. Yu XC, Breitman M, Goldberg J. 2012. A structure-based mechanism for Arf1-dependent recruitment of coatomer to membranes. Cell 148:530-542. doi: 10.1016/j.cell.2012.01.015.